- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-157/17: Action brought on 10 March 2017 — Cristalfarma v EUIPO — Novartis (ILLUMINA)
ECLI:EU:UNKNOWN:62017TN0157
62017TN0157
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
24.4.2017
EN
Official Journal of the European Union
C 129/37
(Case T-157/17)
(2017/C 129/57)
Language in which the application was lodged: English
Parties
Applicant: Cristalfarma Srl (Milan, Italy) (represented by: R. Almaraz Palmero, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Novartis AG (Basel, Switzerland)
Details of the proceedings before EUIPO
Applicant: Applicant
Trade mark at issue: EU word mark ‘ILLUMINA’ — Application for registration No 11 934 239
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 11 January 2017 in Case R 1187/2016-4
Form of order sought
The applicant claims that the Court should:
—annul the contested decision;
—order EUIPO and the other party, should it intervene, to pay the costs of proceedings, including those incurred before the Board of Appeal.
Pleas in law
—Infringement of Article 8(1)(b) of Regulation No 207/2009;
—Infringement of Articles 75, 42(2) and 64(1) of Regulation No 207/2009.